entertainment -WSS

entertainment

author：entertainment 2025-09-28 18:47:31 - browse：92

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： RaDonda Vaught links Vanderbilt hospital issues to patient death

entertainment

WSS

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

ChatGPT in medicine: STAT answers readers' burning questions

Medicare coverage of Wegovy, once blocked, now looks possible

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Pushing for an NIH office for post

23andMe had bad news about my health. I wish a person had delivered it

explore

entertainment

explore

Wildfire smoke exposes gaps in outdoor worker protections

EPA limits use of carcinogenic gas for sterilizing medical devices

How one medical school became remarkably diverse

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Trump demands the U.S. pay no more for drugs than other countries … again

Jerome Adams on the need for new antivirals for Covid

Peter Hotez and the public health issue of online harassment

Steward Health Care Massachusetts hospitals face fiscal disaster

Alkermes shareholders re

FDA approval of Sarepta Duchenne genetic therapy gives me hope

knowledge

First U.S. drug developed to treat liver disease MASH is approved

As demand for Covid shots wanes, Moderna seeks its next success

EPA limits use of carcinogenic gas for sterilizing medical devices

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Steward Health Care Massachusetts hospitals face fiscal disaster

Readout Newsletter: CAR

entertainment

focus

knowledge

explore